Drug Database
Back to search

Netherlands· NL-ea6058b4a77f

Kinidinesulfaat Teva 200 mg, dragees

A quinidine product containing kinidinesulfaat 2-water, registered in Netherlands by Teva Nederland B.V.. The same ATC class is registered in 6 of our 19 countries.

ATC C01BA01

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedKinidinesulfaat Teva 200 mg, drageesATCC01BA01REGISTER NO.NL-ea6058b4a77fPACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about kinidinesulfaat 2-waterAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Quinidine is registered in 6 of 19 countries.

Countries holding a registration under ATC C01BA01 (quinidine), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 3 of them publish a price we can compare per daily dose
Search quinidine products by name

Quinidine · ATC C01BA01

6 / 19 countries

  • Finlandprice
  • Japan
  • Netherlands
  • Norwayprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
KINIDINESULFAAT 2-WATER
Manufacturer
Teva Nederland B.V.
Country
Netherlands (NL)
ATC code
C01BA01
ATC class
Quinidine
Defined daily dose
1.2 g, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    50909

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

491 interactions on record for quinidine.

Graded by severity as the source publishes them — 135 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check quinidine against other medicinesHow interaction checks work

Quinidine · interactions on record

491 records

  • 135 severe
  • 198 moderate
  • 8 minor
  • 108 info

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • OndansetronA04AA01severe
  • GranisetronA04AA02severe

42 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Quinidine in 6 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All quinidine products

Authorised across Europe · EMA

The same active substance is authorised in 2 EEA countries. Names it is sold under:

  • Hungary · Chinidin-Wagner
  • Romania · Chinidina

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/779e0867-aed7-4a2b-b0de-3262c5667d01
GET /v1/drugs/779e0867-aed7-4a2b-b0de-3262c5667d01?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Omhulde tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h50909_smpc.pdf",
  "strength": null,
  "atc_label": "Quinidine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg50909",
  "excipients": [
    "AARDAPPELZETMEEL, GEOXIDEERD EN GEACETYLEERD (E 1451)",
    "BASISCH GEBUTYLEERD METHACRYLAAT COPOLYMEER (E 1205)",
    "CALCIUMCARBONAAT (E 170)",
    "CARNAUBAWAS (E 903)",
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "LACTOSE 1-WATER",
    "MACROGOL",
    "MAGNESIUMSTEARAAT (E 470b)",
    "NATRIUMZETMEELGLYCOLAAT",
    "POLYSORBAAT 80 (E 433)",
    "POVIDON (E 1201)",
    "SACCHAROSE",
    "TALK (E 553b)",
    "TITAANDIOXIDE (E 171)",
    "ZETMEEL, GEPREGELATINEERD"
  ],
  "substances": [
    "KINIDINESULFAAT 2-WATER"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h50909.pdf",
  "authorised_at": "1992/12/31",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "50909",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about quinidine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console